Report

Global Non-Opioid Pain Treatment Market Size study, by Product (Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived), by Application (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others) and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Non-Opioid Pain Treatment Market, by Region, 2018-2027 (USD Million)
1.2.2. Non-Opioid Pain Treatment Market, by Product, 2018-2027 (USD Million)
1.2.3. Non-Opioid Pain Treatment Market, by Application, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Non-Opioid Pain Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Non-Opioid Pain Treatment Market Dynamics
3.1. Non-Opioid Pain Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Non-Opioid Pain Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Non-Opioid Pain Treatment Market, by Product
5.1. Market Snapshot
5.2. Global Non-Opioid Pain Treatment Market by Product, Performance - Potential Analysis
5.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
5.4.1. Medical Cannabis
5.4.2. Menthol-Containing
5.4.3. Omega 3 Fatty Acid-Containing
5.4.4. Botulinum Toxins
5.4.5. Capsaicin-Derived
Chapter 6. Global Non-Opioid Pain Treatment Market, by Application
6.1. Market Snapshot
6.2. Global Non-Opioid Pain Treatment Market by Application, Performance - Potential Analysis
6.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
6.4.1. Orthopaedic and Musculoskeletal Pain
6.4.2. Neuropathic Pain
6.4.3. Cancer Pain
6.4.4. Others
Chapter 7. Global Non-Opioid Pain Treatment Market, Regional Analysis
7.1. Non-Opioid Pain Treatment Market, Regional Market Snapshot
7.2. North America Non-Opioid Pain Treatment Market
7.2.1. U.S. Non-Opioid Pain Treatment Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Non-Opioid Pain Treatment Market
7.3. Europe Non-Opioid Pain Treatment Market Snapshot
7.3.1. U.K. Non-Opioid Pain Treatment Market
7.3.2. Germany Non-Opioid Pain Treatment Market
7.3.3. France Non-Opioid Pain Treatment Market
7.3.4. Spain Non-Opioid Pain Treatment Market
7.3.5. Italy Non-Opioid Pain Treatment Market
7.3.6. Rest of Europe Non-Opioid Pain Treatment Market
7.4. Asia-Pacific Non-Opioid Pain Treatment Market Snapshot
7.4.1. China Non-Opioid Pain Treatment Market
7.4.2. India Non-Opioid Pain Treatment Market
7.4.3. Japan Non-Opioid Pain Treatment Market
7.4.4. Australia Non-Opioid Pain Treatment Market
7.4.5. South Korea Non-Opioid Pain Treatment Market
7.4.6. Rest of Asia Pacific Non-Opioid Pain Treatment Market
7.5. Latin America Non-Opioid Pain Treatment Market Snapshot
7.5.1. Brazil Non-Opioid Pain Treatment Market
7.5.2. Mexico Non-Opioid Pain Treatment Market
7.6. Rest of The World Non-Opioid Pain Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Medropharm Gmbh
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. US Worldmeds LLC
8.2.3. Centrexion Therapeutics Corp.
8.2.4. Tilray, Inc.
8.2.5. GW Pharmaceuticals, plc
8.2.6. Allergan plc
8.2.7. Cronos Group
8.2.8. Medical Marijuana, Inc.
8.2.9. Cara Therapeutics, Inc.
8.2.10. Canopy Growth Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption